0%
Daily Market Update
19-Sep-20251 min readvipin kumar

India’s direct tax collections jump 9.18% to Rs 10.8 Lakh Crore over fewer refunds- Daily Market Update 19th Sept 2025

Get a Smart Summary Instantly

Prompt copied

Net direct tax collections for the financial year 2025-26, as of September 17, 2025, have shown a notable increase, rising by 9.18% to reach over Rs 10.82 lakh crore or $131 billion.
This growth is primarily attributed to a substantial decline in refunds issued by the Income Tax Department, a key indicator of efficiency in tax processing and compliance.

Overview and Outlook

Global Stock Market Today

  • US equity markets settled higher in range 0.25% to 0.94%.
  • European equity markets also ended higher in range 0.20% to 1.33%.
  • Asian equity markets are trading mix.
  • GIFT Nifty is down by 40 points, Nifty futures likely to open around 25471 levels.

 

News highlights from across the globe

  • US Markets rejoiced on account of Federal Reserve rate, with benchmarks reaching all-time highs.
  • Oil pared a second weekly gain after renewed calls by US President Donald Trump to pressure Moscow into lowering prices and ending the war in Ukraine. This weighed against renewed attacks on Russian energy infrastructure.  Brent traded above $67 a barrel.

 

Important news updates from the domestic front

  • Biocon arm Biocon Biologics’ drug Yesafili now publicly funded in Ontario for Advanced treatment of retinal diseases. Yesafili was the 1st Biosimilar to Eylea to be approved by Health Canada.
  • PNC Infratech received a provisional completion certificate for project ‘Four Laning of l.iH 5308 from Mathura Bypass’.
  • Texmaco Rail received Rs 87 crore order from Ultratech Cement for BCFC Wagons along with Brake Van.
  • Kansai Nerolac received a total GST demand of Rs 6.8 crore from Income-Tax Dept.
  • Vedanta declared as a preferred bidder for Punnam Manganese block in Andhra Pradesh.
  • Metropolis Healthcare acquired Ambika Pathology under the business transfer agreement. Post transfer operations of Ambika pathology are now being carried out under the company.
  • Asahi India closes its QIP, approves the allocation of 1.18 crore shares at Issue price of Rs 844.79 per share.
  • Indian Hotels clarifies that the report of sale of New York’s Pierre is misleading and speculative. The company does not own New York’s Pierre.
  • IDBI Bank: Government withdraws nomination of Sushil Kumar Singh as Nominee Director.
  • PC Jeweller approved the allotment of 9.7 crore fully convertible warrant at an issue price of Rs 18 per warrant. Approves Allotment of 18 crore shares at Issue Price of Rs 18 per share.
  • Dr Reddy’s Laboratories receives intimation from Promoters regarding transfer of shares. The promoters settled 20.58% stake through off market transfer on Sept. 17. Promoter Satish Reddy Kallam transferred 9.06% stake to VSD Family Trust. Promoter G V Prasad transferred 11.51% stake to GVP Family Trust.
  • Great Eastern Shipping in a loan agreement with arm Greatship (India) to grant a term loan of Rs 425 crore.

 

Nifty Overview & Outlook

Benchmark Nifty index ended higher above 25400 spot levels after adding 93 points to its previous closing values.

Broader markets performed in line with the benchmark as both Mid and Small cap indices settled on a positive note.

Majority of sectoral indices tracked at NSE ended with marginal gains. Amongst them, Pharma, Health Care and IT index managed to register some meaningful gains, rose in range 0.83% to 1.50%.

Technically, Nifty index is well placed on multiple time frames. However, the possibility of some minor profit taking cannot be ruled out at this juncture. Hence, we continue to uphold our buy on dips trading approach till it is trading above 25100 spot levels on closing basis and expect it to test 25500-25600 spot levels in near term.

 

Derivatives Overview & Outlook

Yesterday, Banknifty and Finnifty futures rose on short covering as both shed 5.5% and 6% of open interest respectively, Midcapnifty futures added 3.6% of open interest as long buildup. On the other hand, no significant changes were seen in Nifty futures on price as well as on open interest front.

Majority of sectoral indices settled on a higher note. Amongst them, Finance, Pharma, Power and Technology stocks witnessed maximum addition of long positions while some short buildup was seen in Chemical stocks.

On options front, put writing along with call addition was seen at higher strikes. Maximum positions are at 25000 PE followed by 25400 PE and 26000 CE followed by 25500 CE.

 

Institutional Trading Activity

Yesterday, FIIs bought stocks worth Rs 367 Cr in the cash segment, bought index futures worth Rs 1347 Cr also bought stocks futures worth Rs 223 Cr. DIIs were too net buyers in the cash segment to the tune of Rs 3327 Cr.

 

Nifty Futures, Banknifty Futures and Finnifty Futures Key Levels

Nifty – Resistances 25550-25620; Supports 25360-25280

Banknifty – Resistances 56000-56200; Supports 55500-55200

Finnifty – Resistances 26820-26900; Supports 26680-26600

 

F&O Security in Ban Today: ANGELONE, RBLBANK & HFCL.

Disclosure

Globe Capital Market Limited (“GCML”) is a Stock Broker registered with BSE, NSE, MCX, NCDEX, and MSEI in all the major segments viz. Capital, F & O and CDS segments. GCML is also a Depository Participant and registered with both the Depositories viz. CDSL and NSDL. Further, GCML is a SEBI registered Portfolio Manager and Research Analyst. GCML includes subsidiaries, group and associate companies, promoters, directors, employees and affiliates.

AY Securities and Commodities Limited, Globe Derivatives and Securities Limited & Globe Fincap Limited are subsidiaries of GCML. AtoZ Finstock Private Limited, A to Z Consultants Private Limited, A to Z Venture Capital Limited, M. Agarwal Stock Brokers Private Limited, A M Share Brokers Private Limited, Shri Adinath Advertising Company Pvt. Ltd., Orient Landbase Private Limited, Bolt Synthetic Private Limited, Price ponder Private Limited, Lakshya Impex Private Limited and Launchpad Fintech Private Limited are associates of GCML.

This report has been prepared by GCML and published in accordance with the provisions of Regulation 19 of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014, for use by the recipient as information only and is not for general circulation or public distribution. This report is not to be altered, transmitted, reproduced, copied, redistributed, uploaded, published or made available to others, in any form, in whole or in part, for any purpose without prior written permission from GCML. The projections and the forecasts described in this report are based on estimates and assumptions and are inherently subject to significant uncertainties and contingencies. Projections and forecasts are necessarily speculative in nature, and it can be expected that one or more of the estimates on which the projections are forecasts were based may not materialize or may vary significantly from actual results and such variations will likely increase over the period of time. This report should not be construed as an offer to sell or the solicitation of an offer to buy, purchase or subscribe to any securities, and neither this report nor anything contained therein shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. It does not constitute a personal recommendation or take into account the particular investment objective, financial situation or needs of any individual in particular. The research analysts of GCML have adhered to the code of conduct under Regulation 24 (2) of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014. The recipients of this report must make their own investment decisions, based on their own investment objectives, financial situation or needs and other factors. The recipients should consider and independently evaluate whether it is suitable for its/ his/ her/their particular circumstances and if necessary, seek professional / financial advice as there is substantial risk of loss. GCML does not take any responsibility thereof.

Any such recipient shall be responsible for conducting his/her/its/their own investigation and analysis of the information contained or referred to in this report and of evaluating the merits and risks involved in securities forming the subject matter of this report. The price and value of the investment referred to in this report and income from them may go up as well as down, and investors may realize profit/loss on their investments. Past performance is not a guide for future performance. Actual results may differ materially from those set forth in the projection.

This report has been prepared by GCML based on the information available in the public domain and other public sources believed to be reliable. Though utmost care has been taken to ensure its accuracy and completeness, no representation or warranty, express or implied is made by GCML that such information is accurate or complete and/or is independently verified. The contents of this report represent the assumptions and projections of GCML and GCML does not guarantee the accuracy or reliability of any projection, assurances or advice made herein. Nothing in this report constitutes investment, legal, accounting and/or tax advice or a representation that any investment or strategy is suitable or appropriate to recipients’ specific circumstances.

Since GCML or its associates are engaged in various financial activities, they might have financial interest or beneficial ownership in various companies including subject company/companies mentioned in the report. GCML or its associates have not received any compensation for investment banking or merchant banking from the subject company in the past 12 months.  GCML or its associates might have received any compensation including brokerage services and for products or services other than investment banking or merchant banking from the subject company in the past 12 months. It is confirmed that GCML or research analyst or its associates have not managed or co-managed public offering of securities for the subject company in the past 12 months.

Research analyst or GCML or its relatives’/associates’ have no material conflict of interest at the time of publication of this report. Neither research analyst nor GCML are engaged in market making activity for the subject company. It is confirmed that research analysts do not serve as an officer, director or employee of the subject company. It is also confirmed that research analyst have not received any compensation from the subject company in the past 12 months. GCML or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.

No material disciplinary action has been taken on GCML by any regulatory authority impacting Equity Research Analysis activities.

The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. This information is subject to change, as per applicable law, without any prior notice. GCML reserves the right to make modifications and alternations to this statement, as may be required, from time to time.

Research analyst or GCML or its relatives’/associates’ do not have actual/beneficial ownership of 1% or more in securities of the subject company, at the end of the month immediately preceding the date of publication of the document.

Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.